A Convenient and Cost Efficient Route Suitable for “One-Pot” Synthesis of Molnupiravir

16 March 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Herein, we reported a convenient and cost efficient one-pot synthesis of molnupiravir from cytidine. This method utilized N,N-dimethylformamide dimethyl acetal (DMF-DMA) as an extraordinary protecting agent to achieve site specific esterification at 5’-hydroxyl group of the nucleoside easily, and afforded this promising drug candidate (purity up to 99%, HPLC a/a) in 70% overall yield without chromatography purification, which is superior to the existing methods in aspect of the yield, the cost and the operation, and shows great potential value for commercial production. Furthermore, this excellent protecting agent was also successfully used in the synthesis of remdesivr from its parent nucleoside with a high total yield (76%).

Keywords

molnupiravir, antiviral, SARS-CoV-2, one-pot synthesis, DMF-DMA, remdesivir

Supplementary materials

Title
Description
Actions
Title
supporting information
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.